Lexicon Pharmaceuticals
LXRX
#6379
Rank
S$1.27 B
Marketcap
S$2.86
Share price
-1.97%
Change (1 day)
98.75%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): S-$0.09026

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$0.08909. In 2025 the company made an earnings per share (EPS) of S-$0.18 an increase over its 2024 EPS that were of S-$0.81.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.09026-49.35%
2025S-$0.18-78.13%
2024S-$0.81-20%
2023S-$1.0231.15%
2022S-$0.78-0%
2021S-$0.7810.91%
2020S-$0.70-145.08%
2019S$1.55-206.09%
2018S-$1.46-5.74%
2017S-$1.55-10.95%
2016S-$1.742640%
2015S-$0.06364-96.34%
2014S-$1.74-2.53%
2013S-$1.78-9.09%
2012S-$1.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
S$23.19-26,128.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$7.04-8,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$54.13-60,857.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S-$7.78 8,628.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$9.98-11,300.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S-$0.02545-71.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S-$0.95 971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$1.78-2,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S-$2,083 2,338,114.29%๐Ÿ‡บ๐Ÿ‡ธ USA